​

Medicus Pharma Stock (NASDAQ:MDCX)

OwnershipFinancialsChart
Medicus Pharma by TradingView

Previous Close

$0.32

52W Range

$0.25 - $3.69

50D Avg

$0.34

200D Avg

$1.38

Market Cap

$7.34M

Avg Vol (3M)

$3.87M

Beta

-0.46

Div Yield

-

MDCX Company Profile

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

12

IPO Date

Nov 15, 2024

Website

MDCX Performance

MDCX Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-34.36M$-11.18M$-4.73M
Net Income-$-11.16M$-5.31M
EBITDA$-34.36M$-11.16M$-586.78K
Basic EPS$-2.74$-1.10$-1.53
Diluted EPS$-2.74$-1.10$-1.53

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
SKYESkye Bioscience, Inc.
COEPCoeptis Therapeutics, Inc.
CUECue Biopharma, Inc.
INMBINmune Bio, Inc.
IPSCCentury Therapeutics, Inc.
BRNSBarinthus Biotherapeutics plc
TELOTelomir Pharmaceuticals, Inc. Common Stock
ALGSAligos Therapeutics, Inc.
KPTIKaryopharm Therapeutics Inc.